Arcadia Biosciences Reports 24% Q3 Revenue Growth and Record Zola Sales

Arcadia Biosciences reported third-quarter 2026 revenue of $1.619 million, up 24% year over year, and record quarterly sales for its Zola brand. Net income attributable to common stockholders was $1.755 million, compared with $856,000 a year earlier. For the first nine months, revenue rose 5% to $4…